Allarity Therapeutics Inc(ALLR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLR Allarity Therapeutics Inc

未开盘 07-22 16:00:00 EDT

1.28

+0.06

+4.92%

盘后1.27

-0.01-0.84%

19:27 EDT

最高1.28	最低1.21	成交量5.71万
今开1.22	昨收1.22	日振幅5.74%
总市值2,025万	流通市值2,022万	总股本1,582万
成交额7.10万	换手率0.36%	流通股本1,579万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLR","market":"US","secType":"STK","nameCN":"Allarity Therapeutics Inc","latestPrice":1.28,"timestamp":1784750400000,"preClose":1.22,"halted":0,"volume":57071,"hourTrading":{"tag":"盘后","latestPrice":1.2692,"preClose":1.28,"latestTime":"19:27 EDT","volume":2688,"amount":3424.1703,"timestamp":1784762868131,"change":-0.0108,"changeRate":-0.008438,"amplitude":0.023438},"delay":0,"changeRate":0.04918032786885251,"floatShares":15794100,"shares":15818980,"eps":-0.721813,"marketStatus":"未开盘","change":0.06,"latestTime":"07-22 16:00:00 EDT","open":1.22,"high":1.28,"low":1.21,"amount":71022.3826186,"amplitude":0.057377,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.721813,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784793600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":1.22,"preHourTrading":{"tag":"盘前","latestPrice":1.2,"preClose":1.22,"latestTime":"08:37 EDT","volume":67,"amount":81.6864,"timestamp":1784723859413,"change":-0.02,"changeRate":-0.016393,"amplitude":0.02082},"postHourTrading":{"tag":"盘后","latestPrice":1.2692,"preClose":1.28,"latestTime":"19:27 EDT","volume":2688,"amount":3424.1703,"timestamp":1784762868131,"change":-0.0108,"changeRate":-0.008438,"amplitude":0.023438},"volumeRatio":0.75008},"requestUrl":"/m/hq/s/ALLR","defaultTab":"news","newsList":[{"id":"1143082028","title":"Allarity Therapeutics获关键美国专利，为其Stenoparib DRP®伴随诊断保驾护航","url":"https://stock-news.laohu8.com/highlight/detail?id=1143082028","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143082028?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:28","pubTimestamp":1783322904,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc 宣布，其用于Stenoparib的DRP®伴随诊断技术已获得一项关键的美国专利授权。\n此项被授予的专利保护期将延长至2042年4月。此外，该公司就Stenoparib DRP在欧洲和澳大利亚的专利保护也已确立，有效期至2039年。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120460888","title":"Allarity Therapeutics公布2026年第一季度业绩并持续推进Stenoparib在多癌种中的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1120460888","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120460888?lang=zh_cn&edition=full","pubTime":"2026-05-16 04:31","pubTimestamp":1778877074,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc公布了其2026年第一季度的财务与业务进展。报告期内，公司核心工作聚焦于其候选药物Stenoparib在多种癌症类型中的持续开发。公司正积极推动该药物的临床研究项目，旨在评估其在治疗不同恶性肿瘤方面的潜力与疗效。这一战略举措体现了Allarity Therapeutics致力于通过创新疗法满足未竟医疗需求的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113205144","title":"Allarity Therapeutics Inc专利预计将在三个月内正式获批，须遵循标准行政程序","url":"https://stock-news.laohu8.com/highlight/detail?id=1113205144","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113205144?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:13","pubTimestamp":1777291992,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics Inc宣布，其专利预计将在未来三个月内获得正式授权，但需经过标准的行政审核流程。\n这一进展标志着公司在知识产权保护方面取得重要突破。专利的正式授予将进一步加强Allarity Therapeutics在相关治疗领域的技术壁垒和竞争优势。\n公司表示，整个授权过程将严格遵循常规行政管理程序，时间表可能存在微调空间。此次专利获批将为公司未来的研发和商业化布局提供有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122429462","title":"Allarity Therapeutics启动VA资助二期试验 首例小细胞肺癌患者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1122429462","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122429462?lang=zh_cn&edition=full","pubTime":"2026-02-18 21:16","pubTimestamp":1771420575,"startTime":"0","endTime":"0","summary":"生物制药公司Allarity Therapeutics Inc宣布，其针对高未满足医疗需求的小细胞肺癌（SCLC）的二期临床试验已完成首例患者给药。该试验获得美国退伍军人事务部（VA）资金支持，旨在评估创新疗法的安全性与有效性。\n小细胞肺癌作为侵袭性极强的癌症类型，长期以来面临治疗选择有限的挑战。此次试验的推进，标志着针对该疾病领域的重要临床突破。公司表示将密切关注试验进展，为后续研发提供关键数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104980685","title":"Allarity Therapeutics Inc提交转售说明书：售股股东拟出售255,103股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1104980685","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104980685?lang=zh_cn&edition=full","pubTime":"2026-02-13 05:39","pubTimestamp":1770932382,"startTime":"0","endTime":"0","summary":"生物技术公司Allarity Therapeutics Inc近日向美国证券交易委员会提交文件，披露其售股股东计划转售255,103股公司普通股。该转售计划将通过招股说明书形式进行，相关股份均由现有股东持有。此次申报标志着公司股权结构可能出现变动，但具体交易细节及时间表尚未公布。作为专注于肿瘤治疗领域的研发型企业，Allarity的资本动态备受市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609587813","title":"Allarity Therapeutics, Inc.盘中异动 临近收盘大幅下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609587813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609587813?lang=zh_cn&edition=full","pubTime":"2026-02-06 04:34","pubTimestamp":1770323687,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日04时34分，Allarity Therapeutics, Inc.股票出现异动，股价大幅跳水5.03%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.53%。其相关个股中，Bone Biologics Corp C/Wts 13/10/2026 、Liminatus Pharma, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Aim Immunotech Inc.、Transcode Therapeutics, Inc.、Propanc Biopharma, Inc.较为活跃，换手率分别为2045.42%、1255.37%、269.96%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Aim Immunotech Inc.、Liminatus Pharma, Inc.，振幅分别为106.67%、68.24%、66.50%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc 是一家临床阶段的精准医学制药公司，专注于为医疗需求未得到满足的患者开发新型的抗癌疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206043447954008a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206043447954008a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","BK4539","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114870357","title":"Allarity Therapeutics与美国退伍军人事务部合作开展Stenoparib联合替莫唑胺治疗复发性小细胞肺癌的II期临床试验现开放入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1114870357","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114870357?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:03","pubTimestamp":1770123805,"startTime":"0","endTime":"0","summary":"Allarity Therapeutics宣布，其与美国退伍军人事务部合作开展的II期临床试验现已开放患者入组。该试验旨在评估Stenoparib与替莫唑胺联合疗法治疗复发性小细胞肺癌的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126939874","title":"Allarity Therapeutics Inc于1月28日与Tumim Stone Capital签署股票购买协议——美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1126939874","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126939874?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:51","pubTimestamp":1769691076,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件，生物制药公司Allarity Therapeutics Inc（简称：ALLR）于1月28日与投资机构Tumim Stone Capital正式达成一项股票购买协议。该协议的签署标志着双方资本合作进入实质性阶段，为Allarity Therapeutics Inc的后续研发及业务拓展提供了资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518627342","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518627342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518627342?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613547,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Allarity Therapeutics, Inc.股票出现波动，股价大幅拉升5.66%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2025.42%、400.50%、57.02%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、珐博进，振幅分别为99.13%、98.72%、98.49%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213227abf2fc69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213227abf2fc69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517146166","title":"Allarity Therapeutics, Inc.盘中异动 快速下挫5.56%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517146166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517146166?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271534,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Allarity Therapeutics, Inc.股票出现波动，股价大幅下挫5.56%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为954.38%、104.36%、49.04%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223214abeb77ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223214abeb77ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856824","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨12.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856824?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:33","pubTimestamp":1740580384,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时33分，Allarity Therapeutics, Inc.股票出现异动，股价急速上涨12.06%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Nutriband Inc C/Wts 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2950.93%、121.39%、91.44%，振幅较大的相关个股有Enveric Biosciences, Inc.、Channel Therapeutics Corporation、Cns Pharmaceuticals, Inc.，振幅分别为78.81%、16.86%、14.35%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223304abdded46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223304abdded46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727011","title":"Allarity Therapeutics, Inc.盘中异动 大幅下跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727011?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:49","pubTimestamp":1740408549,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时49分，Allarity Therapeutics, Inc.股票出现波动，股价大幅跳水5.61%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为123.29%、53.08%、24.85%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Immunic, Inc.，振幅分别为137.23%、21.42%、20.47%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242249109890fa29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242249109890fa29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512957160","title":"Allarity Therapeutics, Inc.盘中异动 股价大涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512957160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512957160?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:03","pubTimestamp":1739898189,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时03分，Allarity Therapeutics, Inc.股票出现波动，股价快速拉升5.30%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Aditxt, Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为461.97%、183.70%、154.75%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010309a24acd65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010309a24acd65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510386063","title":"Allarity Therapeutics, Inc.盘中异动 早盘急速下挫5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510386063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510386063?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:57","pubTimestamp":1739285856,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时57分，Allarity Therapeutics, Inc.股票出现波动，股价大幅下挫5.71%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.26%。其相关个股中，Ocean Biomedical, Inc.、Dominari Holdings Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2422.03%、672.10%、303.16%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical, Inc.，振幅分别为45.29%、37.99%、33.04%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225736abcb0bee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211225736abcb0bee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509740932","title":"Allarity Therapeutics, Inc.盘中异动 大幅跳水5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509740932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509740932?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852336,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，Allarity Therapeutics, Inc.股票出现波动，股价快速跳水5.71%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3890.21%、340.23%、114.95%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Rani Therapeutics Holdings, Inc.、Relmada Therapeutics, Inc.，振幅分别为33.33%、15.97%、14.26%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223216abc4d4a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223216abc4d4a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLR","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506730810","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨8.82%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506730810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506730810?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:33","pubTimestamp":1737988438,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时33分，Allarity Therapeutics, Inc.股票出现波动，股价急速拉升8.82%。截至发稿，该股报1.48美元/股，成交量45.2735万股，换手率10.21%，振幅3.68%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为730.99%、44.39%、40.37%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Evaxion Biotech As，振幅分别为53.75%、28.15%、18.91%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223359a2316b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223359a2316b9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505866102","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨6.06%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505866102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505866102?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:36","pubTimestamp":1737729376,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时36分，Allarity Therapeutics, Inc.股票出现波动，股价大幅上涨6.06%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Pmgc Holdings Inc.、Evaxion Biotech As、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为2095.25%、1274.89%、847.54%，振幅较大的相关个股有Pmgc Holdings Inc.、Evaxion Biotech As、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为40.91%、35.16%、24.58%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223616a22e5b26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223616a22e5b26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501758057","title":"Allarity Therapeutics, Inc.盘中异动 股价大跌6.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501758057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501758057?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:41","pubTimestamp":1736347278,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时41分，Allarity Therapeutics, Inc.股票出现异动，股价快速下挫6.41%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1530.28%、535.88%、508.34%，振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为135.78%、84.85%、68.53%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822411895fd00c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822411895fd00c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ALLR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501584612","title":"Allarity Therapeutics, Inc.盘中异动 早盘快速跳水5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501584612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501584612?lang=zh_cn&edition=full","pubTime":"2025-01-06 22:47","pubTimestamp":1736174837,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日22时47分，Allarity Therapeutics, Inc.股票出现异动，股价快速下挫5.66%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Cns Pharmaceuticals, Inc.、Cytomed Therapeutics Limited、Aditxt, Inc.较为活跃，换手率分别为246.32%、84.40%、64.56%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为39.34%、36.72%、36.57%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622471895fa7601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010622471895fa7601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495615293","title":"Allarity Therapeutics, Inc.盘中异动 早盘股价大涨7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495615293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495615293?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:31","pubTimestamp":1735655494,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时31分，Allarity Therapeutics, Inc.股票出现异动，股价急速拉升7.14%。Allarity Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，知临集团、Onconetix, Inc.、Eyenovia, Inc.涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为876.93%、637.79%、132.85%，振幅较大的相关个股有知临集团、Onconetix, Inc.、Eyenovia, Inc.，振幅分别为54.61%、48.05%、18.27%。Allarity Therapeutics, Inc.公司简介：Allarity Therapeutics Inc是一家临床阶段的精准医疗公司。其管线产品包括Dovitinib, Stenoparib, Ixempra等制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223135ab99820e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231223135ab99820e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLR","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allarity.com","stockEarnings":[{"period":"1week","weight":0.0517},{"period":"1month","weight":-0.1469},{"period":"3month","weight":-0.1286},{"period":"6month","weight":-0.0161},{"period":"1year","weight":0.253},{"period":"ytd","weight":0.1296}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0021},{"period":"3month","weight":0.0521},{"period":"6month","weight":0.0861},{"period":"1year","weight":0.1901},{"period":"ytd","weight":0.0973}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allarity Therapeutics, Inc.于2021年4月6日在特拉华州注册成立。该公司是一家临床阶段的精准医疗制药公司，专注于利用其药物反应预测平台开发抗癌疗法。其主要候选药物stenoparib是一种双重PARP/tankyrase抑制剂，正在开发用于铂耐药卵巢癌和小细胞肺癌，并配套开发伴随诊断试剂以识别可能获益的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.137955},{"month":2,"riseRate":0,"avgChangeRate":-0.233915},{"month":3,"riseRate":0.4,"avgChangeRate":-0.236538},{"month":4,"riseRate":0.4,"avgChangeRate":-0.249609},{"month":5,"riseRate":0.4,"avgChangeRate":-0.030679},{"month":6,"riseRate":0.2,"avgChangeRate":-0.321914},{"month":7,"riseRate":0.2,"avgChangeRate":-0.175152},{"month":8,"riseRate":0.25,"avgChangeRate":0.045342},{"month":9,"riseRate":0.25,"avgChangeRate":-0.31064},{"month":10,"riseRate":0,"avgChangeRate":-0.290985},{"month":11,"riseRate":0,"avgChangeRate":-0.125579},{"month":12,"riseRate":0.25,"avgChangeRate":-0.118424}],"exchange":"NASDAQ","name":"Allarity Therapeutics Inc","nameEN":"Allarity Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allarity Therapeutics Inc(ALLR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allarity Therapeutics Inc(ALLR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allarity Therapeutics Inc,ALLR,Allarity Therapeutics Inc股票,Allarity Therapeutics Inc股票老虎,Allarity Therapeutics Inc股票老虎国际,Allarity Therapeutics Inc行情,Allarity Therapeutics Inc股票行情,Allarity Therapeutics Inc股价,Allarity Therapeutics Inc股市,Allarity Therapeutics Inc股票价格,Allarity Therapeutics Inc股票交易,Allarity Therapeutics Inc股票购买,Allarity Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allarity Therapeutics Inc(ALLR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allarity Therapeutics Inc(ALLR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}